VANGUARD GROUP INC - TALIS BIOMEDICAL CORP ownership

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$223,841
-3.1%
466,336
-1.1%
0.00%
Q1 2023$230,998
+4.9%
471,426
-4.6%
0.00%
Q4 2022$220,247
-36.0%
494,161
-2.2%
0.00%
Q3 2022$344,000
-23.6%
505,086
-8.7%
0.00%
Q2 2022$450,000
-47.9%
553,373
-9.6%
0.00%
Q1 2022$864,000
-70.3%
612,432
-15.5%
0.00%
Q4 2021$2,907,000
-18.2%
725,133
+27.5%
0.00%
Q3 2021$3,555,000
-40.9%
568,757
+4.4%
0.00%
Q2 2021$6,011,000
+19.9%
544,906
+39.7%
0.00%
Q1 2021$5,012,000390,0190.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,095,5340.06%
Baker Brothers Advisors 7,624,835$3,736,1690.02%
PRELUDE CAPITAL MANAGEMENT, LLC 223,934$109,7280.01%
ArrowMark Colorado Holdings LLC 478,862$234,6420.00%
WELLS FARGO & COMPANY/MN 167$820.00%
NORTHERN TRUST CORP 27,860$13,6520.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 144,416$70,7630.00%
STATE STREET CORP 49,536$24,2730.00%
MILLENNIUM MANAGEMENT LLC 163,663$800.00%
View complete list of TALIS BIOMEDICAL CORP shareholders